Koyuncu Ahmet, Çelebi Fahri, Ertekin Erhan, Kahn David A
KOYUNCU: Academy Social Phobia Center, Istanbul, Turkey ÇELEBI: Department of Child and Adolescent Psychiatry, Zonguldak Women and Children Hospital, Zonguldak, Turkey ERTEKIN: Department of Psychiatry, Istanbul Medical School, Istanbul University, Istanbul, Turkey KAHN: Columbia University College of Physicians and Surgeons, New York, NY.
J Psychiatr Pract. 2015 May;21(3):225-31. doi: 10.1097/PRA.0000000000000070.
Social anxiety disorder is frequently comorbid with attention-deficit/hyperactivity disorder (ADHD). However, treatment recommendations are not clear in the presence of such comorbidity. A few studies in the literature have reported improvement in symptoms of both disorders with treatment specific for ADHD (ie, stimulants and atomoxetine). In this report, we present cases of 2 adults with social anxiety disorder and ADHD who were treated with methylphenidate monotherapy. Both cases responded well in terms of not only their ADHD symptoms but also the social anxiety disorder symptoms. Methylphenidate was well tolerated with no significant side effects. More studies are needed to better establish the potential of ADHD medications to be effective for comorbid social anxiety disorder symptoms.
社交焦虑障碍常与注意力缺陷多动障碍（ADHD）共病。然而，在这种共病情况下，治疗建议并不明确。文献中的一些研究报告称，使用针对ADHD的特定治疗方法（即兴奋剂和托莫西汀）可改善两种障碍的症状。在本报告中，我们介绍了2例患有社交焦虑障碍和ADHD的成人患者，他们接受了哌甲酯单一疗法治疗。两例患者不仅ADHD症状得到改善，社交焦虑障碍症状也有改善。哌甲酯耐受性良好，无明显副作用。需要更多研究来更好地确定ADHD药物对共病社交焦虑障碍症状有效的可能性。
